Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Cost-effectiveness analysis of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome in Colombia.

Mejía A, Senior JM, Ceballos M, Atehortúa S, Toro JM, Saldarriaga C, Mejía ME, Ramírez C.

Biomedica. 2015 Dec;35(4):531-40. doi: 10.7705/biomedica.v35i4.2620.

2.

Cost-effectiveness of clopidogrel, prasugrel and ticagrelor for dual antiplatelet therapy after acute coronary syndrome: a decision-analytic model.

Abdel-Qadir H, Roifman I, Wijeysundera HC.

CMAJ Open. 2015 Dec 9;3(4):E438-46. doi: 10.9778/cmajo.20150056. eCollection 2015 Oct-Dec.

3.

The evolution of dual antiplatelet therapy in the setting of acute coronary syndrome: ticagrelor versus clopidogrel.

Amico F, Amico A, Mazzoni J, Moshiyakhov M, Tamparo W.

Postgrad Med. 2015 Dec 10:1-5. [Epub ahead of print]

PMID:
26560350
5.

Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older--rationale and design of the POPular AGE study.

Qaderdan K, Ishak M, Heestermans AA, de Vrey E, Jukema JW, Voskuil M, de Boer MJ, van't Hof AW, Groenemeijer BE, Vos GJ, Janssen PW, Bergmeijer TO, Kelder JC, Deneer VH, ten Berg JM.

Am Heart J. 2015 Nov;170(5):981-985.e1. doi: 10.1016/j.ahj.2015.07.030. Epub 2015 Aug 4.

PMID:
26542508
6.

Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO study.

Goto S, Huang CH, Park SJ, Emanuelsson H, Kimura T.

Circ J. 2015;79(11):2452-60. doi: 10.1253/circj.CJ-15-0112. Epub 2015 Sep 16.

7.

Ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome: A pharmacodynamic analysis.

Chen Y, Dong W, Wan Z, Li Z, Cong H, Hong T, Yin T.

Int J Cardiol. 2015 Dec 15;201:545-6. doi: 10.1016/j.ijcard.2015.06.030. Epub 2015 Jun 19. No abstract available.

PMID:
26325437
8.

Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non-ST-Elevation Acute Coronary Syndrome.

Bavishi C, Panwar S, Messerli FH, Bangalore S.

Am J Cardiol. 2015 Sep 1;116(5):809-17. doi: 10.1016/j.amjcard.2015.05.058. Epub 2015 Jun 4. Review.

PMID:
26119655
9.

Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.

Kang HJ, Clare RM, Gao R, Held C, Himmelmann A, James SK, Lim ST, Santoso A, Yu CM, Wallentin L, Becker RC; PLATO Investigators.

Am Heart J. 2015 Jun;169(6):899-905.e1. doi: 10.1016/j.ahj.2015.03.015. Epub 2015 Mar 31.

10.

Response to letter regarding, "administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome".

Caiazzo G, De Rosa S, Torella D, Spaccarotella C, Mongiardo A, Giampà S, Micieli M, Palella E, Gulletta E, Indolfi C.

Circ Cardiovasc Interv. 2014 Aug;7(4):634. doi: 10.1161/CIRCINTERVENTIONS.114.001716. No abstract available.

11.

[Long-term cost-effectiveness of ticagrelor versus clopidogrel in acute coronary syndrome in Spain].

Molina-Cuadrado E, Mateo-Carrasco H, Nieto-Guindo P, Rodríguez-Gómez P.

Farm Hosp. 2014 Jul 1;38(4):266-75. doi: 10.7399/fh.2014.38.4.1132. Spanish.

12.
14.

Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.

Patel MR, Becker RC, Wojdyla DM, Emanuelsson H, Hiatt WR, Horrow J, Husted S, Mahaffey KW, Steg PG, Storey RF, Wallentin L, James SK.

Eur J Prev Cardiol. 2015 Jun;22(6):734-42. doi: 10.1177/2047487314533215. Epub 2014 May 15.

PMID:
24830710
15.

Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.

Lhermusier T, Voisin S, Murat G, Mejean S, Garcia C, Bataille V, Lipinski MJ, Carrié D, Sié P.

Int J Cardiol. 2014 Jul 1;174(3):874-6. doi: 10.1016/j.ijcard.2014.04.208. Epub 2014 Apr 26. No abstract available.

PMID:
24820749
17.
18.

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.

Lindholm D, Varenhorst C, Cannon CP, Harrington RA, Himmelmann A, Maya J, Husted S, Steg PG, Cornel JH, Storey RF, Stevens SR, Wallentin L, James SK.

Eur Heart J. 2014 Aug 14;35(31):2083-93. doi: 10.1093/eurheartj/ehu160. Epub 2014 Apr 11.

19.

Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelor.

Hansson EC, Rexius H, Dellborg M, Albertsson P, Jeppsson A.

Eur J Cardiothorac Surg. 2014 Oct;46(4):699-705; discussion 705. doi: 10.1093/ejcts/ezt662. Epub 2014 Jan 30.

PMID:
24482383
20.

Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome.

Caiazzo G, De Rosa S, Torella D, Spaccarotella C, Mongiardo A, Giampà S, Micieli M, Palella E, Gulletta E, Indolfi C.

Circ Cardiovasc Interv. 2014 Feb;7(1):104-12. doi: 10.1161/CIRCINTERVENTIONS.113.000512. Epub 2014 Jan 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk